Región Metropolitana de Santiago
Este organismo compró $13.486.726.006.527 en 34.361 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Glaxosmithkline Chile Farmaceutica Limitada.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $951,1 mil M |
| 2025 | $1,7 B |
| 2024 | $1,8 B |
| 2023 | $1,4 B |
| 2022 | $1,1 B |
| 2021 | $1,2 B |
| 2020 | $1,2 B |
| 2019 | $733,5 mil M |
| 2018 | $526,8 mil M |
| 2017 | $476,6 mil M |
| 2016 | $386,6 mil M |
| 2015 | $399,9 mil M |
| 2014 | $267 mil M |
| 2013 | $274,4 mil M |
| 2012 | $223,1 mil M |
| 2011 | $213,6 mil M |
| 2010 | $190,8 mil M |
| 2009 | $204,7 mil M |
| 2008 | $166,3 mil M |
| 2007 | $196,4 mil M |
| 2006 | $27 mil M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 621-493-SE26 | 27-05-2026 | Laboratorio Biotoscana Farma SpA | Aceptada | $1.099.606.339 |
| 621-465-SE26 | 27-05-2026 | Ascend Laboratories SpA | Aceptada | $481.723.900 |
| 621-491-SE26 | 27-05-2026 | Novofarma Service S.A. | Enviada a proveedor | $2.306.846.892 |
| 621-583-SE26 | 26-05-2026 | Sandoz Chile SpA | Enviada a proveedor | $110.697.936 |
| 2268-88-AG26 | 26-05-2026 | Buy Me SpA | Aceptada | $356.976 |
| 621-521-TD26 | 26-05-2026 | Drogueria Global Pharma SpA | Aceptada | $51.623.390 |
| 621-452-SE26 | 26-05-2026 | Luxypharm SpA | Enviada a proveedor | $6.768.322.064 |
| 621-582-TD26 | 26-05-2026 | Inversiones C&a Limitada | Aceptada | $186.568.200 |
| 621-532-SE26 | 26-05-2026 | Alembic Pharmaceuticals SpA | Aceptada | $71.410.853 |
| 621-365-SE26 | 26-05-2026 | Vitafarma S.A. | Aceptada | $467.631.587 |
| 621-325-TD26 | 26-05-2026 | Parthenon Pharma SpA | Aceptada | $5.847.660 |
| 621-417-TD26 | 26-05-2026 | Biogen Chile SpA | Aceptada | $4.014.950.520 |
| 621-541-TD26 | 25-05-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $385.560.000 |
| 621-358-SE26 | 25-05-2026 | Aspen Chile S.A. | Aceptada | $1.177.328.737 |
| 2268-89-CM26 | 25-05-2026 | Compania de Petroleos de Chile Copec S.A. | Enviada a proveedor | $4.000.000 |
| 621-390-SE26 | 20-05-2026 | Centro Especialidades Farmaceuticas Limitada | Aceptada | $466.697.246 |
| 621-409-SE26 | 20-05-2026 | Simil Express S.A. | Aceptada | $4.804.529.800 |
| 621-446-SE26 | 20-05-2026 | Recetario Magistral Endovenoso S.A. | Aceptada | $720.033.300 |
| 621-478-SE26 | 20-05-2026 | Ic Global Chile SpA | Aceptada | $96.699.400 |
| 621-412-SE26 | 19-05-2026 | Luxypharm SpA | Aceptada | $1.970.084.984 |
| 621-481-SE26 | 19-05-2026 | Zericum SpA | Aceptada | $265.543.026 |
| 621-486-SE26 | 19-05-2026 | Lorenzo Jimenez e Hijo Ltda. | Aceptada | $168.561.358 |
| 2268-86-CM26 | 19-05-2026 | Proveedores Integrales Prisa S.A. | Aceptada | $8.829.443 |
| 621-499-SE26 | 19-05-2026 | Neoethicals Chile SpA | Aceptada | $214.704.560 |
| 621-483-SE26 | 19-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $51.905.658 |
| 621-485-SE26 | 19-05-2026 | Alembic Pharmaceuticals SpA | Aceptada | $55.586.935 |
| 621-513-TD26 | 19-05-2026 | Textiles Zahr S.A. | Aceptada | $104.238.973 |
| 621-353-TD26 | 19-05-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $289.170.000 |
| 621-341-TD26 | 19-05-2026 | Abbott Laboratories de Chile Ltda. | Aceptada | $342.223.056 |
| 621-507-TD26 | 19-05-2026 | Textiles Zahr S.A. | Aceptada | $169.543.584 |
